ALPS Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

ALPS Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-57,035	Closed	-$7.99M	–	1057
2018 Q4	$7.99M	Buy	57,035 +3,114	+6%	+$473K	0.06%	128
2018 Q3	$9.21M	Buy	53,921 +10,483	+24%	+$1.76M	0.06%	124
2018 Q2	$7.54M	Buy	43,438 +3,399	+8%	+$511K	0.05%	133
2018 Q1	$4.62M	Buy	40,039 +6,959	+21%	+$740K	0.04%	154
2017 Q4	$2.79M	Buy	33,080 +3,679	+13%	+$307K	0.02%	171
2017 Q3	$2.71M	Buy	29,401 +5,800	+25%	+$451K	0.02%	171
2017 Q2	$1.89M	Buy	23,601 +1,623	+7%	+$89.9K	0.01%	187
2017 Q1	$925K	Buy	21,978 +1,148	+6%	+$47.3K	0.01%	225
2016 Q4	$669K	Sell	20,830 -6,788	-25%	-$174K	﹤0.01%	249
2016 Q3	$723K	Sell	27,618 -2,397	-8%	-$62.7K	0.01%	238
2016 Q2	$696K	Buy	30,015 +8,437	+39%	+$210K	0.01%	218
2016 Q1	$590K	Sell	21,578 -3,698	-15%	-$77.4K	0.01%	206
2015 Q4	$719K	Buy	+25,276	New	+$678K	0.01%	234

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

ALPS Advisors's LOXO Position: Q1 2019 in Review

ALPS Advisors sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 57,035 shares — an estimated $7.99M sold.

ALPS Advisors first reported a position in LOXO in Q4 2015 and held it in 13 quarters. The position peaked at $9.21M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

ALPS Advisors reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
ALPS Advisors sold 57,035 Loxo Oncology, Inc shares in Q1 2019, an estimated $7.99M.
ALPS Advisors first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 13 quarters.
ALPS Advisors's Loxo Oncology, Inc position peaked at $9.21M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on ALPS Advisors's 13F filing for Q1 2019, filed 1 May 2019.